Influenza Testing, Treatment and Vaccination

The California Department of Public Health has issued a clinical advisory to direct clinicians about national influenza testing and treatment recommendations. All patients with suspected or confirmed influenza who are hospitalized, severely ill, or at higher risk for complications should be treated as soon as possible with a neuraminidase inhibitor antiviral agent such as zanamivir or oseltamivir and tested using a real-time reverse polymerase chain reaction (rRT-PCR) assay. The full clinical advisory is linked below.

Other Resources:

Terms of Use  |  Privacy